Functional GPCR Expression in Eukaryotic LEXSY System

J Mol Biol. 2023 Dec 1;435(23):168310. doi: 10.1016/j.jmb.2023.168310. Epub 2023 Oct 6.

Abstract

G protein-coupled receptors (GPCRs) form the largest superfamily of membrane proteins in the human genome, and represent one of the most important classes of drug targets. Their structural studies facilitate rational drug discovery. However, atomic structures of only about 20% of human GPCRs have been solved to date. Recombinant production of GPCRs for structural studies at a large scale is challenging due to their low expression levels and stability. Therefore, in this study, we explored the efficacy of the eukaryotic system LEXSY (Leishmania tarentolae) for GPCR production. We selected the human A2A adenosine receptor (A2AAR), as a model protein, expressed it in LEXSY, purified it, and compared with the same receptor produced in insect cells, which is the most popular expression system for structural studies of GPCRs. The A2AAR purified from both expression systems showed similar purity, stability, ligand-induced conformational changes and structural dynamics, with a remarkably higher protein yield in the case of LEXSY expression. Overall, our results suggest that LEXSY is a promising platform for large-scale production of GPCRs for structural studies.

Keywords: G protein-coupled receptors; Leishmania tarentolae; Protein biophysical characterization; Recombinant expression; Single-molecule Förster Resonance Energy Transfer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Discovery
  • Humans
  • Leishmania
  • Ligands
  • Protein Conformation
  • Protein Stability
  • Receptor, Adenosine A2A* / biosynthesis
  • Receptor, Adenosine A2A* / chemistry
  • Receptors, G-Protein-Coupled* / biosynthesis
  • Receptors, G-Protein-Coupled* / chemistry
  • Recombinant Proteins* / biosynthesis
  • Recombinant Proteins* / chemistry

Substances

  • Receptors, G-Protein-Coupled
  • Recombinant Proteins
  • Receptor, Adenosine A2A
  • Ligands